| Literature DB >> 25419997 |
Zheng-Xi Hu1, Yong-Bo Xue2, Xiao-Bin Bi3, Jin-Wen Zhang4, Zeng-Wei Luo5, Xiao-Nian Li6, Guang-Min Yao7, Jian-Ping Wang8, Yong-Hui Zhang9.
Abstract
Five new compounds, including a benzopyran ribonic glycoside, daldiniside A (1), two isocoumarin ribonic glycosides, daldinisides B (2) and C (3), and two alkaloids, 1-(3-indolyl)-2R,3-dihydroxypropan-1-one (4) and 3-ethyl-2, 5-pyrazinedipropanoic acid (5), along with five known compounds (6-10), were isolated from the EtOAc extract of the marine-associated fungus, Daldinia eschscholzii. Their structures were elucidated by extensive physicochemical and spectroscopic properties, besides comparison with literature data. The absolute configurations of compounds 1-3 were corroborated by chemical transformation, GC analysis and X-ray crystallographic analysis. Meanwhile, the absolute configuration of compound 4 and the planar structure of compound 6 were also determined based on the X-ray diffraction analysis. The cytotoxicity of compounds 1-10, antifungal and anti-HIV activities of compounds 1-5 and the in vitro assay for glucose consumption of compounds 1-3 were done in the anti-diabetic model, whereas none showed obvious activity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25419997 PMCID: PMC4245545 DOI: 10.3390/md12115563
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–10.
1H (400 MHz) and 13C (100 MHz) NMR data for compounds 1–3.
| NO. | 1 a | 2 a | 3 b | |||
|---|---|---|---|---|---|---|
| δH ( | δC | δH ( | δC | δH ( | δC | |
| 1 | 167.8 | 167.0 | ||||
| 2 | 4.21, m | 68.8 | ||||
| 3 | 1.68, ddd (4.1,12.0, 14.4) | 38.9 | 155.9 | 156.7 | ||
| 4 | 5.04, dd (1.9, 4.1) | 60.1 | 6.31, s | 105.8 | 6.40, s | 106.7 |
| 4a | 116.1 | 141.2 | 140.5 | |||
| 5 | 158.6 | 6.58, d (1.8) | 104.5 | 6.70, d (2.1) | 104.3 | |
| 6 | 6.72, d (8.2) | 107.9 | 166.1 | 165.9 | ||
| 7 | 7.12, t (8.2) | 130.5 | 6.62, d (1.8) | 103.9 | 6.89, d (2.1) | 103.7 |
| 8 | 6.49, d (8.2) | 112.0 | 164.5 | 164.1 | ||
| 8a | 157.4 | 101.4 | 101.5 | |||
| 9 | 1.40, d (6.3) | 21.6 | 2.22, s | 19.4 | 2.67, dd (4.9, 14.3) | 44.3 |
| 10 | 4.45, m | 65.4 | ||||
| 11 | 1.40, d (6.2) | 24.4 | ||||
| 1′ | 5.70, d (4.5) | 103.4 | 5.74, d (4.4) | 101.8 | 6.17, d (4.2) | 102.1 |
| 2′ | 4.23, dd (4.5, 6.4) | 73.9 | 4.24, dd (4.4, 6.2) | 73.6 | 4.87, m | 74.1 |
| 3′ | 4.10, dd (2.6, 6.4) | 71.4 | 4.12, dd (3.0, 6.2) | 71.2 | 4.85, m | 71.3 |
| 4′ | 4.20, m | 88.5 | 4.15, m | 88.3 | 4.88, m | 89.0 |
| 5′ | 3.64, dd (3.9, 12.1) | 63.5 | 3.65, dd (3.8, 12.1) | 63.3 | 4.12, dd (3.8, 12.0) | 63.4 |
a Measured in CD3OD; b measured in C5D5N.
Figure 2Selected 1H-1H COSY and HMBC correlations of compounds 1–3.
Figure 3X-ray structure of compound 1.
1H and 13C NMR data for compounds 4–6.
| NO. | 4 c | 5 d | 6 c | |||
|---|---|---|---|---|---|---|
| δH ( | δC | δH ( | δC | δH ( | δC | |
| 1 | 12.03, s | |||||
| 2 | 8.41, s | 134.8 | 152.2 | 153.0 | ||
| 3 | 114.1 | 157.2 | 8.44, d (4.1) | 143.3 | ||
| 3a | 125.9 | |||||
| 4 | 8.21, dd (2.0, 6.6) | 121.4 | ||||
| 5 | 7.19, m | 121.9 | 153.9 | 153.0 | ||
| 6 | 7.23, m | 122.9 | 8.25, s | 141.7 | 8.44, d (4.1) | 143.3 |
| 7 | 7.49, dd (1.7, 6.8) | 112.2 | 3.10, t (7.2) | 29.3 | 2.96, t (7.3) | 29.2 |
| 7a | 136.3 | |||||
| 8 | 195.5 | 2.79, t (7.2) | 32.9 | 2.67, t (7.3) | 32.2 | |
| 9 | 4.69, t (4.5) | 75.8 | 177.1 | 173.8 | ||
| 10 | 3.63, dd (5.5, 11.1) | 65.3 | 3.04, t (7.2) | 30.7 | 2.96, t (7.3) | 29.2 |
| 11 | 2.76, t (7.2) | 33.9 | 2.67, t (7.3) | 32.2 | ||
| 12 | 176.9 | 173.8 | ||||
| 13 | 2.88, q (7.5) | 28.3 | ||||
| 14 | 1.29, t (7.5) | 13.1 | ||||
c Measured in DMSO-d6 on a Bruker AM-400 spectrometer; d measured in CD3OD on a Bruker DRX-600 spectrometer.
Figure 4Selected 1H-1H COSY and HMBC correlations of compounds 4 and 5.
Figure 5X-ray structure of compound 4.
Figure 6X-ray structure of compound 6.